A skin gel containing a nanoemulsion of Phyllanthus emblica branch extract (emblica nanogel) was tested for its safety
and efficacy in a randomized, double-blind, placebo-controlled clinical trial. The patch skin irritation test showed that neither the
emblica nanogel nor the placebo nanogel caused skin erythema. The subjects receiving emblica nanogel had a significantly lower
melanin index of the cheek at weeks 2, 4, 6, and 8, of the forehead at weeks 4, 6, and 8, and of the forearm at week 8 compared to
the placebo group. Skin elasticity was observed to increase for the cheek at week 4, forehead at week 6, and there was no change
for the forearm. The levels of skin moisture and erythema of the subjects were not significantly different from the base line
levels. In conclusion, the application of emblica nanogel resulted in significant skin whitening during the 8 weeks of application.
Keywords
skin whitening, emblica, nanoemulsion, randomized double-blind, clinical trials, melanin index
SONGKLANAKARIN JOURNAL OF SCIENCE & TECHNOLOGY
Published by : Prince of Songkla University Contributions welcome at : http://rdo.psu.ac.th
By using our website, you acknowledge that you have read and understand our Cookie Policy and Privacy Policy.